Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

KOL Investor Event on Iron Deficiency

4 Feb 2022

Shield Therapeutics announces it will host a Key Opinion Leader (“KOL”) event for Investors on “Iron Deficiency Treatment Innovation” with a focus on clinical utility of Accrufer®/Feraccru® on Thursday 10 February 2022 at 10am (EST) / 3pm (GMT).

For more details click here.

Back to news